Studies related to Bilirubin and L-Carnitine

Acetyl-L-carnitine Reduces Depression And Improves Quality Of Life In Patients With Minimal Hepatic Encephalopathy

Effect Decrease
Values Mean and SD. Placebo: before 1.6 ± 0.6, after 1.6 ± 0.4. Carnitine: before 2.3 ± 0.6, after 1.9± 0.3
Trial Design Double blind
Trial Length n/a
Number of Subjects 67
Sex n/a
Notes for this study:
Acetyl-L-Carnitine at 4g a day (2g, twice a day) was associated with decreased depression and improved quality of life as a result of hepatic encepalopathy.

Full details on all 3 studies are available to Examine Members. Try out the Examine Membership with a 14-day free trial.

Already a Member? Log in now to access.